Free Trial

Fulgent Genetics (FLGT) News Today

Fulgent Genetics logo
$17.28 +0.28 (+1.65%)
(As of 11/20/2024 ET)
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Sets New 12-Month Low - Here's Why
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Here's Why
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by StockNews.com
StockNews.com raised Fulgent Genetics from a "sell" rating to a "hold" rating in a report on Tuesday.
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Shares Up 4% - Still a Buy?
Fulgent Genetics (NASDAQ:FLGT) Shares Up 4% - Should You Buy?
Fulgent Genetics price target lowered to $22 from $26 at Piper Sandler
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Given New $22.00 Price Target at Piper Sandler
Piper Sandler dropped their price objective on Fulgent Genetics from $26.00 to $22.00 and set a "neutral" rating for the company in a research report on Monday.
Fulgent Genetics Reports Q3 2024 Financial Performance
Fulgent Genetics Reports Strong Q3 2024 Results
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Trading Down 10.8% - Time to Sell?
Fulgent Genetics (NASDAQ:FLGT) Trading Down 10.8% - Time to Sell?
Fulgent Reports Third Quarter 2024 Financial Results
Fulgent Genetics: EPS Exceeds Forecast
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Releases FY24 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY24 earnings guidance. The company provided EPS guidance of $0.33 for the period, compared to the consensus estimate of ($0.39).
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of 0.330-0.330 for the period, compared to the consensus estimate of -0.390. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $282.2 millionillion.
Fulgent to Participate in Upcoming Conferences
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on Friday
Fulgent Genetics (NASDAQ:FLGT) will be releasing earnings before the market opens on Friday, November 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636991)
Fulgent Genetics Inc.
Fulgent Genetics, Inc. stock logo
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Grows By 5.6%
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 676,100 shares, an increase of 5.6% from the September 30th total of 640,100 shares. Based on an average daily trading volume, of 145,900 shares, the short-interest ratio is currently 4.6 days. Currently, 3.4% of the shares of the company are short sold.
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Here's Why
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low - Time to Sell?
Fulgent Genetics, Inc. stock logo
Fulgent Genetics, Inc. (NASDAQ:FLGT) Sees Significant Drop in Short Interest
Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 640,100 shares, a decline of 11.5% from the September 15th total of 723,200 shares. Currently, 3.2% of the company's shares are short sold. Based on an average trading volume of 166,300 shares, the short-interest ratio is presently 3.8 days.
Fulgent Genetics, Inc. stock logo
Millennium Management LLC Has $18.81 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Millennium Management LLC grew its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 34.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 958,852 shares of the
Fulgent Genetics, Inc. stock logo
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Algert Global LLC
Algert Global LLC boosted its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,440 shares of the company's stock after acq
Fulgent Genetics, Inc. stock logo
Caxton Associates LP Purchases Shares of 25,095 Fulgent Genetics, Inc. (NASDAQ:FLGT)
Caxton Associates LP acquired a new position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 25,095 shares of the company's stock, valued at approximat
Fulgent Genetics, Inc. stock logo
Divisadero Street Capital Management LP Acquires 160,212 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
Divisadero Street Capital Management LP raised its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 46.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 505,212 shares of the company's stock after purchasing an additional 160
Fulgent Genetics, Inc. stock logo
Acadian Asset Management LLC Acquires 53,680 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT)
Acadian Asset Management LLC boosted its holdings in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 593.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 62,724 shares of the company's stock after acqui
Fulgent Genetics, Inc. stock logo
Bank of New York Mellon Corp Has $3.95 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Bank of New York Mellon Corp increased its position in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 37.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 201,201 shares of the company's
Fulgent Genetics, Inc. stock logo
Acuitas Investments LLC Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT)
Acuitas Investments LLC acquired a new stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 49,016 shares of the company's stock, valued at approximately $962,000.
Fulgent Genetics (FLGT) Earnings Dates & Reports
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Down to $25.06
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Down to $25.06
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2024 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.300--0.300 for the period, compared to the consensus estimate of -0.920. The company also issued revenue guidance of $280.0 millionillion-$280.0 millionillion, compared to the consensus estimate of $280.2 millionillion.
Fulgent Genetics, Inc. stock logo
Fulgent Genetics (NASDAQ:FLGT) Shares Up 5.2%
Fulgent Genetics (NASDAQ:FLGT) Shares Up 5.2%
Fulgent Reports Second Quarter 2024 Financial Results
Get Fulgent Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

Click here to get the details.

FLGT Media Mentions By Week

FLGT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FLGT
News Sentiment

0.36

0.46

Average
Medical
News Sentiment

FLGT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FLGT Articles
This Week

4

2

FLGT Articles
Average Week

Get Fulgent Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:FLGT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners